GABRIEL MARTINEZ: Open Payments
NPI 1730686031 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 12 payments from 7 companies in 2025. Trend: 2023 $520 · 2024 $475 · 2025 $374
Food & beverage: $274Education: $100
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $117 |
| E.R. Squibb & Sons, L.L.C. | 3 | $79 |
| Alkermes, Inc. | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Medline Industries LP | 1 | $43 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: COBENFY, ARISTADA, ABILIFY ASIMTUFII, INGREZZA, AUSTEDO XR, INVEGA SUSTENNA.
Industry payments across IN — which companies pay providers there.
